Puma Biotechnology Q1 2024 Adj EPS $(0.05) Beats $(0.22) Estimate, Sales $43.800M Beat $41.050M Estimate
Author: Benzinga Newsdesk | May 02, 2024 05:06pm
Puma Biotechnology (NASDAQ:
PBYI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.22) by 77.27 percent. This is a 155.56 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $43.800 million which beat the analyst consensus estimate of $41.050 million by 6.70 percent. This is a 17.05 percent decrease over sales of $52.800 million the same period last year.
Posted In: PBYI